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Abstract
 
Receptor-interacting protein (RIP) has been reported to associate with tumor necrosis–associated
factor (TRAF)2 and TRAF6. Since TRAF2 and TRAF6 play important roles in CD40 signaling
and TRAF6 plays an important role in TLR4 signaling, we examined the role of RIP in signaling
via CD40 and TLR4. Splenocytes from RIP
 
 
 
/
 
 
 
 mice proliferated and underwent isotype switching
normally in response to anti-CD40–IL-4 but completely failed to do so in response to LPS–IL-4.
However, they normally up-regulated TNF-
 
 
 
 and IL-6 gene expression and CD54 and CD86
surface expression after LPS stimulation. RIP
 
 
 
/
 
 
 
 splenocytes exhibited increased apoptosis and im-
paired Akt phosphorylation after LPS stimulation. These results suggest that RIP is essential for cell
survival after TLR4 signaling and links TLR4 to the phosphatidylinositol 3 kinase–Akt pathway.
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Introduction
 
Receptor-interacting protein (RIP) is a death domain kinase
that associates with tumor necrosis factor receptor (TNFR)1
(1). RIP binds TNFR-associated factor (TRAF)2 (2) and is
essential for TNF-induced NF
 
 
 
B activation and protection
from cell death (3). RIP also interacts with I
 
k
 
B kinase
(IKK)
 
 
 
 (NEMO) (4), which plays a critical role in activa-
tion of the IKK complex, I
 
 
 
B phosphorylation, and NF
 
 
 
B
activation and expression of antiapoptotic genes. RIP interacts
with TRAF6 through the p62 adaptor protein to potentiate
the activation of the IKK complex by TRAF6 (5).
RIP
 
 
 
/
 
 
 
 mice die at 1–3 d of age with apoptosis of lym-
phoid and adipose tissues (3). Their viability is partially rescued
by breeding on the TNFR1
 
 
 
/
 
 
 
 background (6). RIP
 
 
 
/
 
 
 
murine embryonic fibroblasts (MEFs) fail to activate NF
 
 
 
B in
response to TNF-
 
 
 
 and have enhanced sensitivity to TNF-
induced cell death (3). RIP
 
 
 
/
 
 
 
 thymocytes show increased
death, which is rescued by breeding on the TNFR2
 
 
 
/
 
 
 
 back-
ground in an NF
 
 
 
B-independent manner (6).
Ligation of CD40 or TLR4 on B cells leads to prolifera-
tion, isotype switching and up-regulation of the surface
expression of costimulatory molecules (7). B cell activation
via CD40 requires binding of TRAF2 and/or TRAF3 (8).
Binding of TRAF6 controls affinity maturation and the
generation of long-lived plasma cells (9). TLR4 signaling
by LPS activates two major signal transduction pathways.
The first is mediated by MyD88–IRAK–TRAF6 and leads
to the activation of IKK, JNK, and p38. The second,
MyD88-independent pathway, is mediated by TRAM–
TRIF–IRF3 and leads to the expression of type I inter-
ferons and up-regulation of expression of costimulatory
molecules (10). Both pathways are required for optimal ac-
tivation of NF
 
 
 
B and induction of NF
 
 
 
B-dependent genes
(11, 12) and may intersect at the level of TRAF6, as TRIF
interacts with TRAF6 (13).
Other members of the RIP family include RIP2, which
has been implicated in TLR signaling (14, 15), RIP3,
which is not essential for NF
 
 
 
B activation by Toll receptors
(16), and RIP4, which plays an essential role in B cell de-
velopment and activation (17). The fact that RIP interacts
with TRAF2 and TRAF6 prompted us to investigate the
potential role of RIP in CD40 and TLR4 signal transduction.
To address this question, we took advantage of the avail-
ability of RIP
 
 
 
/
 
 
 
 mice.
 
Materials and Methods
 
Mice.
 
Previously generated RIP
 
 
 
/
 
 
 
/TNFR1
 
 
 
/
 
 
 
 mice (6)
were crossed to obtain RIP
 
 
 
/
 
 
 
/TNFR1
 
 
 
/
 
 
 
 double mutant mice.
The pups were chosen at 2–5 d of age as the runts of the litter.
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RIP
 
 
 
/
 
 
 
 homozygous and RIP
 
 
 
/
 
 
 
 heterozygous littermates were
used as controls. Genotype was confirmed by PCR as described pre-
viously (6). Same strain (129 Svev/C57Bl6), age-matched, WT con-
trols were purchased from Jackson Laboratories. Experiments and
animal care were performed according to institutional guidelines.
 
FACS
 
®
 
 Analysis.
 
Single cell suspensions were stained with
FITC-PE–conjugated mAbs or with annexin-FITC as described
previously (8). Quadrants were drawn according to isotype con-
trol staining. FITC- or PE-conjugated mAbs used in these studies
were: anti-CD3, anti-B220, anti-IgM, anti-CD86, and anti-
CD54 (BD Biosciences). For CD54 and CD86 expression, puri-
fied splenic B cells (
 
 
 
80% B220
 
 
 
) obtained by positive selection
using MACS CD45R (B220) MicroBeads (Miltenyi Biotec)
were cultured for 24 h with complete medium (RPMI 1640
from GIBCO BRL supplemented with 10% FBS from Sigma-
Aldrich and 1% penicillin/streptomycin from Life Technologies),
sCD40L (1:20 dilution of supernatants from muCD40L:muCD8-
transfected J558L cells), or LPS (10 
 
 
 
g/ml; Sigma-Aldrich).
 
In Vitro Proliferation and Isotype Switching of B Cells.
 
For pro-
liferation, spleen cells or purified B cells (0.7 
 
 
 
 10
 
6
 
/ml) were cul-
tured in complete medium alone or in the presence of anti-CD40
(1 
 
 
 
g/ml, HM40-3; BD Biosciences) with or without IL-4 (25
ng/ml; R&D Systems), LPS (10 mg/ml) with or without IL-4,
and CpG ODN1826 (10 
 
 
 
M; Invivogen) for 72 h, pulsed with 1
 
 
 
Ci [
 
3
 
H]thymidine for an additional 16 h, harvested, and scintil-
lation was counted. For isotype switching, spleen cells (0.5 
 
 
 
10
 
6
 
/ml) were cultured in complete medium alone or in the pres-
ence of IL-4, anti-CD40 alone or with IL-4, LPS alone or with
IL-4. Supernatants were collected after 6 d, and immunoglobu-
lins were assayed by ELISA as described previously (8).
 
RT-PCR for 
 
 
 
 and 
 
 
 
1 Germ Line Transcripts, Activation-induced
Deaminase, b2-Microglobulin, and mTLR4.
 
RNA was extracted
from 72-h cultured splenocytes using TRIzol (Invitrogen) and
was reverse transcribed using Superscript II RT (Invitrogen).
PCR reactions for 
 
 
 
 and 
 
 
 
1 germ line transcripts (GLTs), activa-
tion-induced deaminase (AID), and 
 
 
 
2-microglobulin and for
mTLR4 were performed as described previously on various dilu-
tions of cDNA to ensure that the products measured were in the
linear range (8, 18). Amplified products were separated on 1%
agarose gels and stained with ethidium bromide.
 
Real-Time PCR for TNF-
 
 
 
 and IL-6 Gene Expression.
 
RNA
was prepared from splenocytes cultured for 16 h with medium or
LPS (10 
 
 
 
g/ml) as above. Real-time quantitative RT-PCR reac-
tions were run on an ABI Prism 7700 (Applied Biosystems) se-
quence detection system platform. Sybr green chemistry was used
for TNF-
 
 
 
 (TNF-
 
  
 
forward, 5
 
 
 
-cccacgtcgtagcaaacc-3
 
 
 
 and TNF-
 
 
 
reverse, 5
 
 
 
-gcagccttgtcccttgaa-3
 
 
 
) and 
 
 
 
-actin. For IL-6, Taqman
primers with FAM-labeled probe (Applied Biosystems) were
used. The relative gene expression among the different samples
was determined using the method described by Pfaffl (19). Melt
curve analysis was performed for products detected by sybr green
to ensure purity of product.
 
Western Blotting.
 
Cell lysates were obtained from splenocytes
(0.5 
 
 
 
 10
 
6
 
 cells/condition) suspended in medium containing 1%
FCS and stimulated with LPS (10 
 
 
 
g/ml) or CpG ODN1826 (3
 
 
 
M) for 15 min. Blots were incubated with antibodies specific for
phospho-Akt, Akt (Becton Dickinson), phospho-p38, or phospho-
I
 
 
 
B (Cell Signaling) followed by horseradish peroxidase–conju-
gated goat anti–rabbit or goat anti–mouse antibodies (Becton
Dickinson). Blots were scanned and OD of bands quantitated using
NIH Image 16.2 software. Fold induction was calculated as the ra-
tio of OD of the phosphoproteins in lysates of LPS-stimulated to
unstimulated cells, each normalized for the OD of their Akt band.
 
Online Supplemental Material.
 
Fig. S1 shows cell lysates that
were obtained from MEFs grown in DME (BioWhittaker) sup-
plemented with 10% FCS and penicillin/streptomycin (100 
 
 
 
g/
ml of each) and left untreated or treated with 100 ng/ml LPS
(Sigma-Aldrich) or 10 ng/ml IL-1
 
 
 
 (R&D Systems). IKK activ-
ity in the cell lysates was detected using an anti-phospho-I
 
 
 
B–
specific antibody (Cell Signaling). IKK levels were also compared
in these lysates using an anti-IKK
 
 
 
 rabbit antibody (Santa Cruz
Biotechnology, Inc.). Fig. S1 available at http://www.jem.org/
cgi/content/full/jem.20040446/DC1.
 
Results and Discussion
 
RIP
 
   
 
/TNFR1
 
   
 
 Mice Have Normal Percentages of
B Cells in Their Spleens.
 
Splenocytes were taken from
RIP
 
 
 
/
 
 
 
/TNFR1
 
 
 
/
 
 
 
 pups and RIP
 
 
 
/
 
 
 
/TNFR1
 
 
 
/
 
 
 
 litter-
mates. Because in all experiments splenocytes from RIP
 
 
 
/
 
 
 
/
TNFR1
 
 
 
/
 
 
 
 and RIP
 
 
 
/
 
 
 
/TNFR1
 
 
 
/
 
 
 
 littermates behaved
identically, we present data only on RIP
 
 
 
/
 
 
 
/TNFR1
 
 
 
/
 
 
 
controls. Total number of splenocytes was comparable be-
tween RIP
 
 
 
/
 
 
 
/TNFR1
 
 
 
/
 
 
 
 and age-matched WT controls
but was significantly lower in the double mutant mice
(6.2 
 
 
 
 10
 
6 
 
  
 
2 versus 20 
 
  
 
106   6 in littermate controls
and 2   106   8 in WT controls). The three- to fourfold
decrease in splenocyte number in RIP / /TNFR1 / 
pups is commensurate with the threefold reduction in the
weight of these pups (3).
The percentages of B cells, B cell subsets, and T cells
were assessed by FACS® analysis (Fig. 1). The percentage
of B220  cells was comparable in spleens from RIP / /
TNFR1 /  pups and RIP / /TNFR1 /  littermates.
This is consistent with normal B cell development in
RIP /  embryos (3) and with the observation that recon-
stitution of irradiated WT and RAG1 /  mice with fetal
liver cells from RIP /  embryos results in normal B cell
development (6). More importantly, the percentages of
mature B220 sIgM  cells were comparable in splenocytes
Figure 1. Splenocyte phenotype. FACS® analysis of B and T cell pop-
ulations in total splenocytes from a RIP / /TNFR1 /  mouse and a
RIP / /TNFR1 /  littermate, representative of three experiments per-
formed. Percentages of total splenocytes are shown.Vivarelli et al. Brief Definitive Report 401
from RIP / /TNFR1 /  pups and RIP / /TNFR1 / 
littermates. The decreased percentage of CD3  cells in
spleens of RIP / /TNFR1 /  pups is consistent with the
deleterious effect of RIP disruption on thymocyte develop-
ment (6). Spleen cell populations of RIP / /TNFR1 / 
littermates were comparable to those present in age-
matched WT controls (unpublished data). This is consistent
with the observation that TNFR1 /  mice have normal B
cell development (20).
RIP   /TNFR1    B Cells Fail To Proliferate Specifically
in Response to LPS. Splenocytes from RIP / /TNFR1 / 
mice proliferated normally in response to anti-CD40  
IL-4, whereas they completely failed to proliferate in re-
sponse to LPS. This failure was not rescued by IL-4 (Fig. 2
A). This result was confirmed in two separate experiments
performed on purified B cells (unpublished data), suggest-
ing that the failure to proliferate to LPS reflects an intrinsic
defect in B cells. The failure of B cells from RIP / /
TNFR1 /  to proliferate to LPS was not simply due to
lack of TLR4 expression. RT-PCR analysis of mRNA re-
vealed TLR4 expression in purified B cells from RIP / /
TNFR1 /  and RIP / /TNFR1 /  littermates (Fig. 2 B).
TLR9 engagement by the ligand CpG ODN 1826 also
causes B cell proliferation (21). TLR9-induced prolifera-
tion was significantly impaired in splenocytes from RIP   /
TNFR1    mice (Fig. 2 C).
RIP   /TNFR1    B Cells Have Severely Impaired IgG1
and IgE Isotype Switching in Response To LPS 1 IL-4. To
further assess the response of B cells from RIP / /
TNFR1 /  pups to LPS, we examined the ability of sple-
nocytes from these mice and littermate controls to secrete
IgG1 and IgE in response to stimulation with LPS   IL-4
or anti-CD40   IL-4. Splenocytes from the double mu-
tant mice secreted normal amounts of IgG1 and IgE in re-
sponse to anti-CD40   IL-4 but were severely impaired in
their ability to secrete IgG1 and IgE in response to LPS  
IL-4 (Fig. 2, D and E). The molecular events involved in
isotype switching in naïve B cells include expression of
GLTs and expression of the gene for AID, followed by de-
letional switch recombination and expression of mature
post switch transcripts (7). LPS induces expression of the
AID gene and synergizes with IL-4 in inducing the expres-
sion of C 1 and C  GLTs to result in isotype switching to
IgG1 and IgE. The ability of LPS to activate these events
in B cells from RIP / /TNFR1 /  pups and littermate
controls was examined. LPS by itself induced AID gene
expression in RIP / /TNFR1 /  B cells and synergized
with IL-4 to induce C 1 and C  GLTs in these cells (Fig.
2 F). In contrast, LPS failed to induce detectable AID gene
expression in RIP / /TNFR1 /  B cells and synergized
poorly with IL-4 in inducing expression of C 1 GLT and
AID in these cells. LPS also failed to synergize with IL-4 in
inducing detectable C  GLT in RIP / /TNFR1 /  B
cells. The defect in isotype switching of RIP / /
TNFR1 /  B cells in response to LPS is not due to a gen-
eralized defect in these cells because CD40 ligation syner-
gized with IL-4 to induce expression of C 1 GLT, C 
GLT, and AID in RIP / /TNFR1 /   pups that was
comparable to that observed in littermate controls. Since
LPS induction of isotype switching in B cells has been
Figure 2. B cell proliferation and
immunoglobulin synthesis. (A) Pro-
liferation of splenocytes from RIP / /
TNFR1 /  pups (n     7) and
RIP / /TNFR1 /  littermates (n
  7) stimulated for 72 h with anti-
CD40 mAb   IL-4 and LPS   IL-4.
**P     0.005. (B) Expression of
mTLR4 in B220  B cells from
RIP / /TNFR1 /  and RIP / /
TNFR1 /  mice. (C) Proliferation
of splenocytes from RIP / /
TNFR1 /  pups (n     4) and
RIP / /TNFR1 /  littermates (n
  4) stimulated for 72 h with CpG
ODN 1826. **P   0.005 IgG1 (D)
and IgE (E) in supernatants 6 d after
stimulation of total splenocytes from
RIP / /TNFR1 /  pups (n   9)
and RIP / /TNFR1 /  littermates
(n   10). **P   0.005. (F) Molecular
events of isotype switching. Expres-
sion of C 1, C , and AID transcripts
measured by RT-PCR in total sple-
nocytes stimulated for 72 h with
anti-CD40 mAb   IL-4 and LPS  
IL-4. The dotted lines show where
irrelevant lanes were cut out. Similar
results were obtained in three inde-
pendent experiments.RIP Links TLR4 to Akt 402
shown to be division linked (22), the failure of RIP-defi-
cient B cells to undergo isotype switching in response to
LPS may reflect their failure to proliferate.
LPS Induction of TNF-  and IL-6 Expression Is Normal in
RIP   /TNFR1    Splenocytes. LPS stimulation of sple-
nocytes induces the expression of several NF B-dependent
genes that include IL-6 and TNF- , which are primarily
expressed in macrophages and dendritic cells (23). LPS up-
regulated IL-6 and TNF-  mRNA expression in spleno-
cytes from RIP / /TNFR1 /  mice to an extent that was
equivalent to that induced in splenocytes from RIP / /
TNFR1 /  littermates (Fig. 3, A and B). This suggests that
RIP is not essential for LPS-induced NF B activation and
is consistent with previous observations that LPS and IL-1
induce a normal NF B response in RIP    thymocytes
and MEFs (reference 3 and Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20040446/DC1). In
contrast, RIP2 has been shown to be important for LPS ac-
tivation of NF B and induction of IL-6 and TNF-  gene
expression (14, 15).
Up-regulation of CD54 and CD86 Surface Expression Is
Normal in RIP   /TNFR1    B Cells. LPS and CD40
ligation up-regulate the expression of several surface mark-
ers on B cells including the adhesion molecule CD54
Figure 3. Cytokine gene expression. Induction of mRNA for IL-6 (A) and TNF-  (B) by LPS in RIP / /TNFR1 /  pups (n   3) and RIP / /
TNFR1 /  controls (n   3). Values show the fold induction over unstimulated control splenocytes cultured with medium as determined by real time
PCR. (C) Up-regulation of CD86 and CD54 expression on B cells. B220  cells from RIP / /TNFR1 /  and RIP / /TNFR1 /  mice were left un-
stimulated (green) or were stimulated for 24 h with sCD40L (blue) or LPS (red). Similar results were obtained in four independent experiments (one
using purified B cells).
Figure 4. Apoptosis and expression of Akt after LPS stimulation of splenocytes from RIP / /TNFR1 /  pups and RIP / /TNFR1 /  littermates.
(A) Annexin V–FITC and B220-PE staining at 0, 16, and 96 h of splenocytes cultured with medium or LPS. Analysis was performed by gating on B220 
cells. Similar results were obtained in two separate experiments. (B) Akt, I B, and p38 phosphorylation after stimulation of RIP / /TNFR1 /  and
RIP / /TNFR1 /  splenocytes with LPS (n   4) or CpG ODN 1826 (n   2). Lysates were probed with Akt as loading control. (C) Fold induction of
Akt, I B, and p38 phosphorylation after LPS stimulation (n   4) *P   0.05.Vivarelli et al. Brief Definitive Report 403
(ICAM-1) and the costimulatory molecule CD86 (B7.2)
(24). The TRIF–IRF3 type I interferon pathway is essen-
tial for the up-regulation by LPS of the costimulatory mol-
ecule CD86, whose promoter contains STAT sites that are
potential targets of type I interferon–activated STATs but
no NF B sites (25). LPS stimulation of purified splenic B
cells caused comparable up-regulation in the surface ex-
pression of CD54 and CD86 on B cells from RIP / /
TNFR1 /  pups and control RIP / /TNFR1 /  litter-
mates (Fig. 3 C). B cells from RIP / /TNFR1 /  pups
also normally up-regulated CD54 and CD86 expression in
response to CD40 ligation. These results suggest that
TLR4 signaling via the TRAM–TRIF–IRF3 pathway is
preserved in RIP-deficient B cells.
RIP Is Essential for Cell Survival After LPS Stimulation.
The observation that relatively early events after TLR4 sig-
naling, e.g., up-regulation of surface markers and cytokine
gene expression, were preserved, whereas later events, e.g.,
proliferation and isotype switching, were severely impaired
in RIP-deficient splenocytes prompted us to examine the
survival of these cells after sTLR4 ligation. Splenocytes
were cultured with medium or LPS, and apoptosis was as-
sessed at 0, 16, and 96 h by staining with annexin V–FITC
and B220-PE. Fig. 4 A shows that the percentage of an-
nexin V –B220  cells in unstimulated cultures and in cul-
tures stimulated with LPS for 16 h was equivalent for
RIP / /TNFR1 /  and RIP / /TNFR1 /  B cells. In
contrast, the percentage of annexin V –B220  cells in cul-
tures stimulated with LPS for 96 h was higher for RIP / /
TNFR1 /  than RIP / /TNFR1 /  mice (92 versus
64%, n   2). Conversely, the percentage of viable annexin
V –B220  cells is lower in RIP / /TNFR1 /  than in
RIP / /TNFR1 /  B cells (8 versus 36%, n   2). LPS
stimulation of RIP / /TNFR1 /  splenocytes also caused
increased apoptosis of B220  non–B cells. The percentage
of annexin V –B220  non–B cells at 96 h was 72.5% in
RIP / /TNFR1 /  splenocytes versus 28% in RIP / /
TNFR1 /  splenocytes (n   2). These results suggest that
RIP plays an important role in cell survival after TLR4 li-
gation. The observation that TLR4 induced normal ex-
pression of NF B-dependent genes in RIP-deficient
splenocytes suggests that, as in thymocytes and MEFs (ref-
erence 3 and Fig. S1), RIP mediates survival signals in
LPS-stimulated splenocytes independently of NF B and
that NF B activation is not sufficient to promote the sur-
vival of LPS-stimulated B cells.
RIP Is Important for Akt Phosphorylation After TLR4 Sig-
naling. Phosphatidylinositol (PI)3 kinase is activated after
TLR4 signaling, leading to the phosphorylation and activa-
tion of Akt, which plays an important role in B cell survival
(26). More importantly, p85 -deficient B cells have im-
paired proliferation and increased apoptosis after LPS stimu-
lation (27). We used a phosphospecific antibody to examine
Akt phosphorylation after LPS stimulation in RIP / /
TNFR1 /  splenocytes and control RIP / /TNFR1 / 
splenocytes. LPS stimulation caused Akt phosphorylation in
RIP / /TNFR1 /  splenocytes. In contrast, LPS induced
virtually no Akt phosphorylation in RIP   /TNFR1   
splenocytes (Fig. 3, B and C; n   4). The decrease in Akt
phosphorylation was specific because LPS induced normal
phosphorylation of I B and p38 in these cells (Fig. 3, B and
C; n   4). RIP   /TNFR1    splenocytes also had se-
verely impaired Akt phosphorylation after CpG stimulation,
but CpG induced I B and p38 phosphorylation in these
cells (Fig. 3 B; n   2). These results suggest that RIP links
TLR4 and TLR9 signaling to PI3 kinase activation. Analy-
sis of Akt phosphorylation in subpopulations of purified cells
was precluded by the decreased splenic cellularity and young
age of RIP   /TNFR1    pups.
LPS-induced PI3 kinase activation is dependent on
TAK1 (28), which interacts with RIP (29). Our data sug-
gests that RIP is essential for TAK1-dependent TLR4 and
TLR9 activation of PI3 kinase. The role of RIP in Akt ac-
tivation by other TLR ligands and the exact molecular link
between RIP and Akt remain to be elucidated. Although
our data on splenocytes and MEFs suggests that RIP is not
essential for TLR4 activation of NF B, recent work indi-
cates that RIP interacts with TRIF and is important for
NF B activation by TLR3 (30), as it is for NF B activa-
tion by TNFR1. This suggests that RIP plays different
roles in signaling by individual TLRs.
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